Brian C. Broderick’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18M Buy
73,536
+3,396
+5% +$791K 3.31% 9
2025
Q4
$14.5M Sell
70,140
-140
-0.2% -$27.7K 2.74% 12
2025
Q3
$13M Sell
70,280
-1,834
-3% -$314K 2.48% 16
2025
Q2
$11M Sell
72,114
-4,833
-6% -$743K 2.18% 20
2025
Q1
$12.8M Sell
76,947
-1,359
-2% -$213K 2.6% 17
2024
Q4
$11.3M Sell
78,306
-1,762
-2% -$273K 2.22% 21
2024
Q3
$13M Sell
80,068
-889
-1% -$142K 2.54% 17
2024
Q2
$11.8M Buy
80,957
+1,649
+2% +$245K 2.42% 18
2024
Q1
$12.5M Buy
79,308
+3,233
+4% +$515K 2.68% 14
2023
Q4
$11.9M Buy
76,075
+3,843
+5% +$589K 2.98% 14
2023
Q3
$11.3M Buy
72,232
+1,293
+2% +$213K 3.1% 12
2023
Q2
$11.7M Buy
70,939
+1,167
+2% +$188K 3.1% 13
2023
Q1
$10.8M Buy
69,772
+68
+0.1% +$11K 3.04% 13
2022
Q4
$12.3M Buy
69,704
+736
+1% +$127K 3.65% 8
2022
Q3
$11.3M Buy
68,968
+1,457
+2% +$247K 3.52% 8
2022
Q2
$12M Sell
67,511
-397
-0.6% -$70.7K 3.63% 8
2022
Q1
$12M Buy
67,908
+130
+0.2% +$22.1K 3.08% 12
2021
Q4
$11.6M Buy
67,778
+2,650
+4% +$434K 2.79% 15
2021
Q3
$10.5M Sell
65,128
-788
-1% -$134K 2.81% 15
2021
Q2
$10.9M Sell
65,916
-326
-0.5% -$54K 2.88% 10
2021
Q1
$10.9M Sell
66,242
-139
-0.2% -$22.5K 3.13% 10
2020
Q4
$10.4M Sell
66,381
-109
-0.2% -$16.1K 3.1% 11
2020
Q3
$9.9M Sell
66,490
-1,677
-2% -$248K 3.15% 10
2020
Q2
$9.59M Sell
68,167
-1,061
-2% -$155K 3.19% 7
2020
Q1
$9.08M Buy
69,228
+193
+0.3% +$27.4K 3.59% 5
2019
Q4
$10.1M Buy
69,035
+1,597
+2% +$217K 3.26% 5
2019
Q3
$8.72M Buy
67,438
+73
+0.1% +$9.62K 3% 8
2019
Q2
$9.38M Sell
67,365
-2,080
-3% -$288K 3.28% 6
2019
Q1
$9.71M Buy
69,445
+1,349
+2% +$181K 3.47% 2
2018
Q4
$8.79M Sell
68,096
-760
-1% -$106K 3.7% 2
2018
Q3
$9.51M Buy
68,856
+73
+0.1% +$9.7K 3.23% 5
2018
Q2
$8.35M Buy
68,783
+867
+1% +$108K 3.05% 5
2018
Q1
$8.7M Sell
67,916
-1,078
-2% -$146K 3.26% 2
2017
Q4
$9.64M Sell
68,994
-8,827
-11% -$1.23M 3.52% 1
2017
Q3
$10.1M Sell
77,821
-5,738
-7% -$761K 3.65% 1
2017
Q2
$11.1M Sell
83,559
-1,180
-1% -$151K 4.09% 1
2017
Q1
$10.6M Sell
84,739
-1,252
-1% -$150K 4.3% 1
2016
Q4
$9.9M Sell
85,991
-935
-1% -$108K 4.29% 1
2016
Q3
$10.3M Sell
86,926
-2,734
-3% -$332K 4.38% 2
2016
Q2
$10.9M Sell
89,660
-769
-0.9% -$87.4K 4.58% 1
2016
Q1
$9.78M Buy
90,429
+3,865
+4% +$400K 4.24% 2
2015
Q4
$8.89M Buy
86,564
+4,675
+6% +$470K 3.98% 2
2015
Q3
$7.64M Buy
81,889
+1,835
+2% +$178K 3.54% 3
2015
Q2
$7.8M Sell
80,054
-1,225
-2% -$123K 3.32% 4
2015
Q1
$8.18M Buy
81,279
+3,715
+5% +$378K 3.39% 3
2014
Q4
$8.11M Buy
77,564
+2,485
+3% +$262K 3.44% 4
2014
Q3
$8M Sell
75,079
-766
-1% -$79.4K 3.56% 3
2014
Q2
$7.93M Sell
75,845
-920
-1% -$93K 3.63% 3
2014
Q1
$7.54M Sell
76,765
-2,512
-3% -$233K 3.71% 3
2013
Q4
$7.26M Sell
79,277
-4,666
-6% -$430K 3.61% 3
2013
Q3
$7.28M Sell
83,943
-5,933
-7% -$532K 4.06% 3
2013
Q2
$7.72M Buy
+89,876
New +$7.63M 4.62% 3

Other funds holding JNJ

Brian C. Broderick's JNJ Position: Q1 2026 in Review

Brian C. Broderick increased its Johnson & Johnson (JNJ) stake by 4.8% in Q1 2026, buying an estimated $791K and bringing the position to 73,536 shares worth $18M. The position accounts for 3.31% of the portfolio, ranked #9.

Brian C. Broderick first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Brian C. Broderick held 73,536 shares of Johnson & Johnson worth $18M as of Q1 2026.
  • Brian C. Broderick bought 3,396 Johnson & Johnson shares in Q1 2026, an estimated $791K.
  • Johnson & Johnson made up 3.31% of Brian C. Broderick's portfolio in Q1 2026, its #9 holding.
  • Brian C. Broderick first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Brian C. Broderick's 13F filing for Q1 2026, filed 7 May 2026.